adenosine has been researched along with Acute Kidney Failure in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (8.33) | 18.7374 |
1990's | 26 (36.11) | 18.2507 |
2000's | 12 (16.67) | 29.6817 |
2010's | 18 (25.00) | 24.3611 |
2020's | 10 (13.89) | 2.80 |
Authors | Studies |
---|---|
Dong, Z; Kwon, SH; Lee, BR; Lee, CM; Lee, HK; Lee, TJ; Li, C; O'Connor, PM | 1 |
Carney, EF | 1 |
Bai, R; Ni, L; Wu, X; Yuan, C; Zhou, LT; Zhou, Q | 1 |
Hussein, RM; Salama, M; Saleh, H | 1 |
Jackson, EK; Kessinger, CJ; Kitsios, GD; Lu, MY; Macatangay, BJC; McVerry, BJ; Morris, A; Schaefer, CM | 1 |
Kurata, Y; Mimura, I; Nangaku, M; Tanaka, T; Yamazaki, T | 1 |
Dwyer, KM; Kishore, BK; Robson, SC | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Aggarwal, D; Gupta, K; Joshi, JC; Kumari, A; Mehra, K; Pandey, S; Sen, P; Sharma, VV; Singh, G; Singh, R | 1 |
Murphy, GJ; Patel, NN; Qureshi, SH | 1 |
Bayliss, G; Guan, Y; Tolbert, T; Zang, X; Zhao, TC; Zhou, X; Zhuang, S | 1 |
An, X; Cao, W; Huang, Z; Li, Q; Liu, X; Wu, L; Xing, C; Yuan, Y; Zhang, A; Zhang, B | 1 |
Hou, X; Liu, N; Ni, J; Qiu, A; Shi, Y; Wang, X; Xu, L; Zheng, X; Zhuang, S | 1 |
Chen, RY; Han, CH; Mou, S; Wu, JJ; Xia, L; Xu, Y; Yuan, XD; Zhang, M | 1 |
Brown, KM; D'Agati, VD; Ham, A; Kim, JY; Kim, M; Lee, HT | 1 |
Brown, KM; D'Agati, VD; Greene, RW; Ham, A; Kim, JY; Kim, M; Lee, HT | 1 |
Kinsey, GR; Okusa, MD; Sharma, R | 1 |
Abe, T; Akamatsu, Y; Akiyama, Y; Araki, K; Araki, M; Bonventre, JV; Ichimura, T; Imai, Y; Inoue, C; Inoue, R; Ito, K; Ito, S; Itoh, K; Jinno, D; Kawagisihi, N; Masuda, S; Mishima, E; Miyagi, S; Mount, DB; Ohkubo, T; Sabbisetti, V; Saigusa, D; Saiki, Y; Shima, H; Shimizu, R; Shinke, H; Soga, T; Suzuki, C; Suzuki, T; Suzuki, Y; Takeuchi, Y; Tominaga, T; Tomioka, Y; Toyohara, T; Tsukui, Y; Yamamura, K | 1 |
Masereeuw, R; Peters, E; Pickkers, P | 1 |
Bootsma, HP; de Jong, B; Feith, GW; Van der Veen, MJ; van Vuren, AJ | 1 |
Okusa, MD; Vincent, IS | 1 |
Osswald, H; Vallon, V | 1 |
Brown, JR; Mautone, A | 1 |
Bauerle, JD; Eltzschig, HK; Grenz, A; Kim, JH; Lee, HT | 1 |
Lee, HT; Yap, SC | 1 |
Ambler, K; Badulak, A; Bauerle, JD; Blackburn, MR; Brodsky, KS; Choi, DS; Christians, U; Clambey, E; Coe, IR; Dalton, JH; Eltzschig, HK; Grenz, A; Haase, VH; Klawitter, J; Lukashev, D; Magee, K; McNamee, EN; Moldovan, R; Nürnberg, B; Osswald, H; Ravid, K; Reyes, G; Ridyard, D; Sitkovsky, M; Tak, E; Wen, J; Xia, Y | 1 |
El-Gowelli, HM; El-Mas, MM; Ghazal, AR; Harraz, OF; Mohy El-Din, MM | 1 |
Blume, C; Falk, CS; Felix, A; Gueler, F; Haller, H; Schrader, J; Shushakova, N | 1 |
Brown, KM; D'Agati, VD; Haase, VH; Kim, JY; Kim, M; Lee, HT; Park, SW | 1 |
D'Agati, VD; Emala, CW; Jacobson, MA; Lee, HT; Ota-Setlik, A; Xu, H | 1 |
Emala, CW; Lee, HT; Nasr, SH; Schnermann, J; Xu, H | 1 |
Itoh, Y; Oishi, R; Sendo, T; Yano, T | 1 |
Koike, K; Okuda, S | 1 |
Adam, A; Becker, CR; Davidson, C; Lameire, N; McCullough, PA; Stacul, F; Tumlin, J | 1 |
Eckle, T; Eltzschig, HK; Grenz, A; Kloor, D; Köhle, C; Mittelbronn, M; Osswald, H; Thompson, LF; Wehrmann, M; Zhang, H | 1 |
Eckle, T; Eltzschig, HK; Grenz, A; Hermes, M; Huang, DY; Klingel, K; Müller, CE; Osswald, H; Robson, SC; Zhang, H | 1 |
Gouyon, JB; Grimaldi, M; Guignard, JP; Huet, F; Semama, D | 1 |
Gleiter, C; Mühlbauer, B; Osswald, H | 1 |
Bohle, A; Erley, C; Kokot, F; Osswald, H; Risler, T; Schubert, B; Wehrmann, M | 1 |
Bohle, A; Duda, SH; Erley, CM; Huppert, PE; Koehler, J; Osswald, H; Risler, T; Schlepckow, S; Strohmaier, WL | 1 |
Karasawa, A; Kusaka, H | 1 |
Karasawa, A; Kubo, K; Mizumoto, H | 1 |
Ishikawa, I; Sato, Y; Shikura, N; Takada, K | 1 |
Guignard, JP; Huet, F; John, E; Semama, D | 1 |
Ishikawa, I; Shikura, N; Takada, K | 1 |
Gleiter, C; Osswald, H | 1 |
Bowmer, CJ; Gould, J; Yates, MS | 1 |
Mühlbauer, B; Osswald, H; Vallon, V | 1 |
Burgert, K; Erley, CM; Heyne, N; Langanke, J; Osswald, H; Risler, T | 1 |
De Backer, JP; De Bruyne, T; Hasrat, JA; Vauquelin, G; Vlietinck, AJ | 1 |
Thijs, A; Thijs, LG | 1 |
Erley, CM; Heyne, N; Osswald, H; Risler, T; Rossmeier, S; Vogel, T | 1 |
Iwao, H; Kim, S; Miura, K; Okumura, M; Yamanaka, S | 1 |
Yao, K | 1 |
Kellum, JA; Venkataraman, R | 1 |
Gross, JM; King, BF; Knox, FG; Larson, TS; Nath, KA; Pflueger, A | 1 |
Baumert, H; Carretier, M; Eugene, M; Gibelin, H; Goujon, JM; Hameury, F; Hauet, T | 1 |
Bowmer, CJ; Collis, MG; Munsey, TS; Panjehshahin, MR; Yates, MS | 1 |
Ishii, A; Karasawa, A; Kawakita, T; Kubo, K; Mizumoto, H; Nonaka, H; Shimada, J; Suzuki, F | 1 |
Bowmer, CJ; Collis, MG; Knight, RJ; Yates, MS | 1 |
Hishida, A; Kato, A | 1 |
Takabatake, T; Ushiogi, Y | 1 |
Bohle, A; Christensen, J; Kendziorra, H; Kokot, F; Marcovic-Lipkovski, J; Osswald, H; Pressler, H; Schubert, B | 1 |
Baumelou, A; Baumelou, B; Cacoub, P; Deray, G; Jacobs, C; Martinez, F | 1 |
Bidani, A; Churchill, P; Ellis, V; Gunther, S; Kontry, T; Rossi, N | 1 |
Gouyon, JB; Guignard, JP | 3 |
Firth, JD; Ledingham, JG; Raine, AE; Ratcliffe, PJ | 1 |
Bowmer, CJ; Collis, MG; Yates, MS | 1 |
Bidani, AK; Churchill, PC; Lin, JJ | 1 |
24 review(s) available for adenosine and Acute Kidney Failure
Article | Year |
---|---|
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Topics: 5'-Nucleotidase; Acute Kidney Injury; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Carcinoma, Renal Cell; Diabetic Nephropathies; Graft Rejection; Humans; Immune Tolerance; Inflammation; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Macrophages; Polycystic Kidney Diseases; Receptors, Purinergic P1; Receptors, Purinergic P2; Renal Insufficiency, Chronic; Reperfusion Injury; Signal Transduction; T-Lymphocytes, Regulatory | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
"Adenosine an old player with new possibilities in kidney diseases": Preclinical evidences and clinical perspectives.
Topics: Acute Kidney Injury; Adenosine; Adenosine Kinase; Animals; Humans; Kidney Diseases; Receptors, Purinergic P1; Reperfusion Injury | 2021 |
Regulatory T cells in AKI.
Topics: Acute Kidney Injury; Adenosine; Adoptive Transfer; Animals; Humans; T-Lymphocytes, Regulatory | 2013 |
The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cattle; Clinical Trials, Phase II as Topic; Critical Illness; Drug Evaluation, Preclinical; Endotoxemia; Forecasting; Humans; Intestines; Multicenter Studies as Topic; Receptors, Purinergic P1; Recombinant Fusion Proteins; Sepsis | 2014 |
Adenosine 2A receptors in acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Animals; Dendritic Cells; Humans; Macrophages; Mice; Models, Cardiovascular; Nephritis; Receptor, Adenosine A2A | 2015 |
Adenosine receptors and the kidney.
Topics: Acute Kidney Injury; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Glomerular Filtration Rate; Humans; Kidney; Receptor, Adenosine A1; Receptors, Purinergic P1; Renin; Theophylline | 2009 |
Contrast-induced nephropathy in patients undergoing elective and urgent procedures.
Topics: Acetylcysteine; Acute Disease; Acute Kidney Injury; Adenosine; Ascorbic Acid; Contrast Media; Elective Surgical Procedures; Emergency Treatment; Free Radical Scavengers; General Surgery; Glomerular Filtration Rate; Humans; Hydrotherapy; Preoperative Care; Renal Dialysis; Risk Assessment; Sodium Bicarbonate | 2010 |
Adenosine generation and signaling during acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Animals; Humans; Ischemia; Kidney; Mice; Models, Animal; Receptors, Purinergic P1; Signal Transduction | 2011 |
Adenosine and protection from acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Animals; Cytoprotection; Humans; Kidney; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction | 2012 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atrial Natriuretic Factor; Contrast Media; Diuretics; Endothelins; Epoprostenol; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Iodine Radioisotopes; Kidney Tubules; Models, Biological; Renal Dialysis; Risk Factors | 2005 |
[Contrast nephropathy and heavy metal nephrotoxicity].
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Contrast Media; Endothelins; Heavy Metal Poisoning; Humans; Nitric Oxide; Nitric Oxide Synthase; Reactive Oxygen Species; Renal Circulation | 2006 |
Pathophysiology of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Adenosine; Biomarkers; Consensus Development Conferences as Topic; Contrast Media; Embolism, Cholesterol; Endothelins; Humans; Kidney Tubules; Nitric Oxide; Reactive Oxygen Species; Renal Circulation; Reperfusion; Sodium; Vasoconstriction | 2006 |
Therapeutic use of theophylline to antagonize renal effects of adenosine.
Topics: Acute Kidney Injury; Adenosine; Animals; Contrast Media; Erythropoietin; Humans; Kidney; Purinergic P1 Receptor Antagonists; Renal Circulation; Theophylline; Vasoconstriction | 1995 |
[Acute noninflammatory renal failure. New pathogenetic aspects in light of findings obtained in autopsy and biopsy of kidneys].
Topics: Acute Kidney Injury; Adenosine; Animals; Biopsy; Humans; Kidney; Male; Oliguria; Polyuria; Renin-Angiotensin System | 1994 |
Acute renal failure.
Topics: Acute Disease; Acute Kidney Injury; Adenosine; Age Factors; Angiotensin II; Animals; Animals, Newborn; Blood Flow Velocity; Calcium Channels; Disease Models, Animal; Endothelins; Free Radicals; Glomerular Filtration Rate; Humans; Hypoxia; Infant, Newborn; Rabbits; Reactive Oxygen Species; Renal Circulation; Risk Factors | 1993 |
[Renal effects of adenosine: possible consequences for kidney transplantation].
Topics: Acute Kidney Injury; Adenosine; Animals; Energy Metabolism; Hemodynamics; Humans; Kidney; Kidney Function Tests; Kidney Transplantation; Organ Preservation; Vascular Resistance | 1993 |
Role of adenosine in tubuloglomerular feedback and acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Feedback; Glomerular Filtration Rate; Humans; Kidney Tubules; Renal Blood Flow, Effective; Vasoconstriction | 1996 |
Pathogenesis of renal failure in sepsis.
Topics: Acute Kidney Injury; Adenosine; Endothelin-1; Humans; Interleukins; Leukotrienes; Nitric Oxide; Platelet Activating Factor; Renal Circulation; Sepsis; Tumor Necrosis Factor-alpha | 1998 |
Novel approaches to the treatment of acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Dopamine Agonists; Endothelin Receptor Antagonists; Growth Substances; Humans; Natriuretic Agents; Renal Agents | 2000 |
Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus.
Topics: Acute Kidney Injury; Adenosine; Contrast Media; Diabetes Complications; Humans; Osmolar Concentration; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Risk Factors | 2000 |
Adenosine in the immature kidney.
Topics: Acute Kidney Injury; Adenosine; Animals; Humans; Kidney | 1989 |
Endothelin: an important factor in acute renal failure?
Topics: Acute Kidney Injury; Adenosine; Animals; Dose-Response Relationship, Drug; Endothelins; Glomerular Filtration Rate; Kidney; Peptides; Rats; Renal Circulation | 1988 |
Functional renal insufficiency: role of adenosine.
Topics: Acute Kidney Injury; Adenosine; Animals; Glomerular Filtration Rate; Humans; Hypoxia; Renal Circulation | 1988 |
3 trial(s) available for adenosine and Acute Kidney Failure
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Effects of theophylline on renal insufficiency in neonates with respiratory distress syndrome.
Topics: Acute Kidney Injury; Adenosine; Fatal Outcome; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Male; Respiratory Distress Syndrome, Newborn; Theophylline; Vasodilator Agents | 1995 |
Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application.
Topics: Acute Kidney Injury; Adenosine; Aldosterone; Contrast Media; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Iohexol; Male; Middle Aged; Prospective Studies; Renin; Theophylline | 1994 |
46 other study(ies) available for adenosine and Acute Kidney Failure
Article | Year |
---|---|
Differential release of extracellular vesicle tRNA from oxidative stressed renal cells and ischemic kidneys.
Topics: Acute Kidney Injury; Adenosine; Animals; Cell Line; Disease Models, Animal; Extracellular Vesicles; Ischemia; Kidney; Methylation; Mice; Oxidative Stress; Rats, Sprague-Dawley; Repressor Proteins; RNA, Transfer; Transcription, Genetic | 2022 |
METTL3 contributes to the pathogenesis of AKI.
Topics: Acute Kidney Injury; Adenosine; Humans; Methyltransferases | 2022 |
The Correlation between Ferroptosis and m6A Methylation in Patients with Acute Kidney Injury.
Topics: Acute Kidney Injury; Adenosine; Amino Acid Transport System ASC; Ferroptosis; Humans; Methylation; Minor Histocompatibility Antigens | 2022 |
Polyethylene glycol capped gold nanoparticles ameliorate renal ischemia-reperfusion injury in diabetic mice through AMPK-Nrf2 signaling pathway.
Topics: Acute Kidney Injury; Adenosine; AMP-Activated Protein Kinases; Animals; Antioxidants; Creatinine; Diabetes Mellitus, Experimental; Gold; Kidney; Male; Malondialdehyde; Metal Nanoparticles; Mice; NF-E2-Related Factor 2; Oxidative Stress; Phosphatidylinositol 3-Kinases; Polyethylene Glycols; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Signal Transduction; Streptozocin; Tumor Necrosis Factor-alpha | 2022 |
Suppressed renoprotective purines in COVID-19 patients with acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Adenosine Monophosphate; Animals; COVID-19; Guanosine; Guanosine Monophosphate; Inosine; Purines | 2022 |
Dznep, a histone modification inhibitor, inhibits HIF1α binding to TIMP2 gene and suppresses TIMP2 expression under hypoxia.
Topics: Acute Kidney Injury; Adenosine; Animals; Disease Models, Animal; Epigenesis, Genetic; Histone Code; Humans; Mice; Tissue Inhibitor of Metalloproteinase-2 | 2023 |
Vascular endothelial cell changes in postcardiac surgery acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Animals; Antigens, CD; Cadherins; Capillary Permeability; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Disease Models, Animal; Endothelial Cells; Female; Glomerular Filtration Rate; Glycocalyx; Glycosaminoglycans; Kidney; Microcirculation; Renal Circulation; Sus scrofa; Thrombomodulin | 2018 |
Targeting enhancer of zeste homolog 2 protects against acute kidney injury.
Topics: Acute Kidney Injury; Adenosine; Adherens Junctions; Animals; Apoptosis; Cadherins; Cells, Cultured; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Epithelial Cells; Folic Acid; Hydrogen Peroxide; Jumonji Domain-Containing Histone Demethylases; Kidney; Kidney Tubules; Lipocalin-2; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Phosphatidylethanolamine Binding Protein; Phosphorylation; Proto-Oncogene Proteins c-raf; Reperfusion Injury; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Zonula Occludens-1 Protein | 2018 |
Adenosine kinase inhibition protects against cisplatin-induced nephrotoxicity.
Topics: Acute Kidney Injury; Adenosine; Adenosine Kinase; Animals; Apoptosis; Cell Line; Cisplatin; Disease Models, Animal; Humans; Inflammation Mediators; Kidney; Male; Mice, Inbred C57BL; Morpholines; Oxidative Stress; Protein Kinase Inhibitors; Pyrimidines; Reactive Oxygen Species; Receptors, Purinergic P1; Signal Transduction; Up-Regulation | 2019 |
3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Topics: Acute Kidney Injury; Adenosine; Animals; Apoptosis; Cadherins; Caspase 3; Cell Line; Cell Line, Tumor; Cisplatin; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Histones; Humans; JNK Mitogen-Activated Protein Kinases; Kidney Function Tests; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Protective Agents; RNA, Small Interfering; Signal Transduction | 2019 |
The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1.
Topics: Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Animals; Cell Cycle Proteins; Disease Progression; DNA Methylation; Humans; Male; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Protective Agents; Reperfusion Injury; Signal Transduction; Transcription Factors; YAP-Signaling Proteins | 2020 |
The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury.
Topics: 5'-Nucleotidase; Acute Kidney Injury; Adenosine; Anesthetics, Inhalation; Animals; Antibodies, Neutralizing; Apoptosis; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Isoflurane; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Neutrophil Infiltration; Purinergic P1 Receptor Antagonists; Reperfusion Injury; RNA, Messenger; Time Factors; Transforming Growth Factor beta1; Volatilization | 2013 |
IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI.
Topics: Acute Kidney Injury; Adenosine; Adenosine A1 Receptor Agonists; Animals; Cell Line; Humans; Interleukin-11; Male; Mice; Mice, Inbred C57BL; Receptor, Adenosine A1; Reperfusion Injury | 2013 |
Conformational change in transfer RNA is an early indicator of acute cellular damage.
Topics: Acute Kidney Injury; Adenosine; Aged; Animals; Apoptosis; Case-Control Studies; DNA Damage; Female; Humans; Japan; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Molecular Conformation; Oxidative Stress; Rats, Wistar; Renal Insufficiency, Chronic; RNA, Transfer | 2014 |
Ticagrelor-induced renal failure leading to statin-induced rhabdomyolysis.
Topics: Acute Kidney Injury; Adenosine; Aged; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rhabdomyolysis; Rosuvastatin Calcium; Ticagrelor | 2015 |
Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice.
Topics: Acute Kidney Injury; Adenosine; Animals; Cell Line; Chimerism; Dipyridamole; Equilibrative Nucleoside Transporter 1; Humans; Ischemia; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; No-Reflow Phenomenon; Nucleoside Transport Proteins; Phosphodiesterase Inhibitors; Receptors, Purinergic P1; Regional Blood Flow | 2012 |
Adenosinergic modulation of the imidazoline I₁-receptor-dependent hypotensive effect of ethanol in acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Ethanol; Hypotension; Imidazoles; Imidazoline Receptors; Male; Rats; Rats, Wistar | 2012 |
Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injury.
Topics: 5'-Nucleotidase; Acute Kidney Injury; Adenosine; Animals; Autoimmunity; Capillaries; Cell Count; Chemokine CXCL2; Complement C3; Endothelial Cells; Immunoglobulin G; Interleukin-18; Male; Mesangial Cells; Mice; Phenotype; Podocytes; Proteinuria; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Endothelial Growth Factor A | 2012 |
Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia.
Topics: Acute Kidney Injury; Adenosine; Adenosine A1 Receptor Agonists; Animals; Kidney; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Statistical; Phosphotransferases (Alcohol Group Acceptor); Receptor, Adenosine A1; Receptors, Lysosphingolipid; Reperfusion Injury | 2012 |
A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Genotype; Histamine; Ischemia; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Myoglobinuria; p-Methoxy-N-methylphenethylamine; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Reference Values; Renal Circulation; Reperfusion Injury | 2003 |
A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion.
Topics: Acute Kidney Injury; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Apoptosis; Biomarkers; Genotype; In Situ Nick-End Labeling; Intercellular Adhesion Molecule-1; Interleukin-1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Neutrophils; Receptor, Adenosine A1; Reperfusion Injury; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthines | 2004 |
Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
Topics: 5'-Nucleotidase; Acute Kidney Injury; Adenosine; Animals; Disease Models, Animal; Ischemia; Ischemic Preconditioning; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout | 2007 |
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury.
Topics: Acute Kidney Injury; Adenosine; Animals; Antigens, CD; Apyrase; Female; Ischemic Preconditioning; Kidney; Kidney Function Tests; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Renal Artery; Renal Circulation; Reperfusion Injury | 2007 |
Effects of repeated administration of KW-3902, a novel adenosine A1-receptor antagonist, on its pharmacological actions.
Topics: Acute Kidney Injury; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Oral; Animals; Diuretics; Furosemide; Glycerol; Heart Rate; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Trichlormethiazide; Urination; Xanthines | 1993 |
Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
Topics: Absorption; Acute Kidney Injury; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Blood Urea Nitrogen; Creatinine; Diuretics; Glycerol; GTP-Binding Proteins; Kidney; Kidney Tubules; Male; p-Aminohippuric Acid; Pertussis Toxin; Purinergic Antagonists; Rats; Rats, Wistar; Sensitivity and Specificity; Sodium; Virulence Factors, Bordetella; Water; Xanthines | 1993 |
[Recent advances in the research on the acute renal failure--pathophysiological aspect].
Topics: Acute Kidney Injury; Adenosine; Animals; Endothelins; Epidermal Growth Factor; Heat-Shock Proteins; Hepatocyte Growth Factor; Humans; Male; Oxygen; Purinergic Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley | 1993 |
Changes of adenosine levels in the carotid artery, renal vein and inferior vena cava after glycerol or mercury injection in the rat.
Topics: Acute Kidney Injury; Adenosine; Animals; Carotid Arteries; Glycerol; Mercuric Chloride; Purinergic Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Renal Veins; Time Factors; Vena Cava, Inferior | 1993 |
Amelioration of glycerol-induced acute renal failure in rats by an adenosine A1 receptor antagonist (FR-113453).
Topics: Acute Kidney Injury; Adenosine; Adenosine Triphosphate; Animals; Creatinine; Glycerol; Kidney; Magnetic Resonance Spectroscopy; Purinergic Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors | 1993 |
Renal haemodynamic responses to adenosine in acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Disease Models, Animal; Glycerol; Hemodynamics; Male; Mercuric Chloride; Rats; Rats, Wistar; Renal Circulation; Vasoconstriction; Xanthines | 1995 |
Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency.
Topics: Acute Kidney Injury; Adenosine; Animals; Blood Pressure; Contrast Media; Disease Models, Animal; Enzyme Inhibitors; Glomerular Filtration Rate; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Renal Circulation; Theophylline; Vasoconstriction; Xanthines | 1997 |
Cirsimarin and cirsimaritin, flavonoids of Microtea debilis (Phytolaccaceae) with adenosine antagonistic properties in rats: leads for new therapeutics in acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Female; Flavones; Flavonoids; GABA Agonists; Glycosides; Hemodynamics; Ligands; Male; Rats; Rats, Wistar; Receptors, Purinergic P1; Vasodilator Agents | 1997 |
Adenosine and extracellular volume in radiocontrast media-induced nephropathy.
Topics: Acute Kidney Injury; Adenosine; Animals; Blood Pressure; Contrast Media; Enzyme Inhibitors; Extracellular Space; Hematocrit; Hypertension, Renal; Kidney; Male; NG-Nitroarginine Methyl Ester; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Water; Xanthines | 1998 |
No participation of adenosine A1 receptor in acute nephrotoxicity by 4-pentenoic acid administration in dogs.
Topics: Acute Kidney Injury; Adenosine; Animals; Diuretics; Dogs; Fatty Acids, Monounsaturated; Female; Glomerular Filtration Rate; Infusions, Intra-Arterial; Kidney; Male; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Xanthines | 1999 |
[Effect of KW-3902, a selective adenosine A1-receptor antagonist, on accumulation of gentamicin in the proximal renal tubules in rats].
Topics: Acute Kidney Injury; Adenosine; Animals; Anti-Bacterial Agents; Gentamicins; Kidney Tubules, Proximal; Male; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines | 2000 |
Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury.
Topics: Acetic Acid; Acetylglucosaminidase; Acute Kidney Injury; Adenosine; Allopurinol; Animals; Biomarkers; Citric Acid; Cold Temperature; Creatinine; Dimethylamines; Glutathione; Glutathione Transferase; Hypertonic Solutions; Insulin; Isoenzymes; Kidney; Kidney Medulla; Kidney Transplantation; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Methylamines; Organ Preservation; Organ Preservation Solutions; Raffinose; Reperfusion Injury; Swine; Transplantation, Autologous | 2000 |
Further characterization of the protective effect of 8-cyclopentyl-1,3-dipropylxanthine on glycerol-induced acute renal failure in the rat.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Kidney Injury; Adenosine; Animals; Creatinine; Glycerol; Kidney; Male; Rats; Rats, Inbred Strains; Renal Circulation; Theophylline; Urea | 1992 |
Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Cations, Monovalent; Diuretics; Male; Potassium; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Purinergic; Sodium; Structure-Activity Relationship; Xanthines | 1992 |
Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine.
Topics: Acute Kidney Injury; Adenosine; Animals; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Electrolytes; Heart Rate; In Vitro Techniques; Kidney; Male; Organ Size; p-Aminohippuric Acid; Rats; Rats, Inbred Strains; Urea; Xanthines | 1991 |
[The pathophysiologic mechanisms of acute renal failure].
Topics: Acute Kidney Injury; Adenosine; Animals; Atrial Natriuretic Factor; Capillary Permeability; Endothelins; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Kidney Tubules; Necrosis; Renal Circulation; Renin-Angiotensin System | 1991 |
[Tubuloglomerular feedback].
Topics: Acute Kidney Injury; Adenosine; Animals; Calcium Channel Blockers; Diuretics; Energy Metabolism; Feedback; Glomerular Filtration Rate; Humans; Kidney Tubules; Renin-Angiotensin System; Signal Transduction; Sodium Chloride | 1991 |
Acute renal failure in man: new aspects concerning pathogenesis. A morphometric study.
Topics: Acute Kidney Injury; Adenosine; ADP-Ribosylation Factor 6; Adult; Biopsy; Epithelium; Female; Humans; Juxtaglomerular Apparatus; Kidney; Kidney Tubules; Male; Renin-Angiotensin System | 1990 |
A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction.
Topics: Acute Kidney Injury; Adenosine; Animals; Biological Transport, Active; Calcium; Contrast Media; Diatrizoate Meglumine; Diltiazem; Dogs; Female; Ischemia; Male; Renal Circulation; Sodium; Theophylline; Vasoconstriction; Verapamil | 1990 |
The role of adenosine in HgCl2-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Adenosine; Animals; Dose-Response Relationship, Drug; Hemodynamics; In Vitro Techniques; Kidney; Mercuric Chloride; Perfusion; Rats; Rats, Inbred Strains; Renal Circulation; Theophylline | 1990 |
[Vasomotor kidney failure in the newborn infant. Physiopathology and treatment].
Topics: Acute Kidney Injury; Adenosine; Blood Volume; Dopamine; Furosemide; Humans; Indomethacin; Infant, Newborn; Renin-Angiotensin System; Respiration, Artificial; Tolazoline | 1989 |
Effect of the adenosine antagonist 8-phenyltheophylline on glycerol-induced acute renal failure in the rat.
Topics: Acute Kidney Injury; Adenosine; Animals; Creatinine; Glycerol; Heart Rate; Inulin; Kidney; Male; Organ Size; Rats; Rats, Inbred Strains; Theophylline; Urea | 1986 |
Effect of theophylline on the initiation phase of postischemic acute renal failure in rats.
Topics: Acute Kidney Injury; Adenosine; Animals; Blood Pressure; Body Weight; Glomerular Filtration Rate; Inulin; Male; Potassium; Rats; Rats, Inbred Strains; Renal Artery Obstruction; Renal Circulation; Sodium; Theophylline | 1986 |